Mike Patterson, Curium’s North American Chief Executive Officer said: “Customers are looking to simplify their business. Our generic version of DTPA allows Curium to offer a more comprehensive list of ...

GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American ...

GE HealthCare has raised the curtain on a new CT system with features designed specifically for addressing cardiovascular ...

GE HealthCare Technologies Inc. GEHC recently announced the U.S. launch of Flyrcado (flurpiridaz F 18) injection at the ongoing American College of Cardiology (ACC) Annual Scientific Session & Expo.

GE HealthCare’s Revolution Vibe is an ‘all-in-one’ system aimed at boosting the accessibility of CT angiography (CCTA).

Introduced at ACC.25, the Revolution Vibe CT system includes Unlimited One-Beat Cardiac imaging and combines with GE HealthCare’s ECG-less Cardiac, TrueFidelity DL, SnapShot Freeze 2, and Effortless ...

The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.

Similarly, AI in nuclear cardiac imaging detects subtle perfusion defects, improving the diagnosis of coronary artery disease by up to 14%. With advancements in 4D flow analysis, AI enables ...

Per GE HealthCare’s estimates, around six million myocardial perfusion imaging (MPI) procedures are undertaken each year in the United States to show blood flow through the heart muscle and ...